NDC 71839-104
fosaprepitant 150 mg per 5 mL injection, powder, lyophilized, for solution
On the label: BE Pharmaceuticals Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Be Biosol Private Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyNov 12, 2024 · 3 inspections |
Recalls
- Jan 10, 2024 · Class II · Be Pharmaceuticals Ag
Lack of Sterility Assurance: Aseptic process simulation failure.
Lots: lot #13D012AA, Exp: 08/31/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Aprepitant: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 150 mg per 5 mL
- Approval
- ANDA ANDA212309
- On the market since
- Oct 15, 2019
- Package NDCs
71839-104-01- Official label
- DailyMed (National Library of Medicine), updated Oct 9, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?